Table 4.
Arterial stiffness parameters in patients with type 2 diabetes mellitus and cardiac autonomic neuropathy
| Parameter | Control (n = 12) | Patients with T2DM without CVD and CAN (n = 12) | Patients with T2DM and CAN (n = 21) |
| 1st group | 2nd group | 3rd group | |
| AIxao (%) | 20.6 ± 1.71 | 26.7 ± 1.84a | 33.7 ± 1.24ce |
| AIxbr (%) | -33.7 ± 2.86 | -23.4 ± 1.91b | -7.9 ± 2.67cf |
| PWV (m/s) | 7.2 ± 0.31 | 8.9 ± 0.25c | 11.1 ± 0.39cf |
| AASI | 0.3 ± 0.02 | 0.36 ± 0.02a | 0.47 ± 0.03ce |
Δ%, Mean ± SEM;
a
P < 0.05,
b
P < 0.01,
c
P < 0.001 - compared to 1st group;
e
P < 0.01,
f
P < 0.001 - compared to 2nd group. T2DM: Type 2 diabetes mellitus; CAN: Cardiac autonomic neuropathy; CVD: Cardiovascular diseases; AIxao: Aortha augmentation index; AIxbr: Brachial augmentation index; PWV: Pulse wave velocity; AASI: Ambulatory arterial stiffness index.